LONDON, Oct 22 (Reuters) - Drugmakers will work together toaccelerate development of an Ebola vaccine and Johnson & Johnson and GlaxSmithKline, both of which haveexperimental vaccine candidates, have already discussedcollaboration.
J&J, which aims to have at least 1 million doses of itstwo-step vaccine available next year, said on Wednesday thatvaccine makers would work together to maximise production ofwhich ever vaccine proved successful in clinical trials.
Paul Stoffels, head of research at J&J, told reporters itwas also possible that rival vaccines being developed by J&J andGSK could potentially be combined, if that looked like the mostpromising approach. (Reporting by Ben Hirschler, editing by Louise Heavens)